Hui Tian

机构：Johnson & Johnson (United States), Education Department of Heilongjiang Province · ORCID：0000-0002-8932-3003

发表论文 152 篇 · 总被引 3014 次 · h-index 28

代表论文

• Chemically engineered antibodies for autophagy-based receptor degradation (2025 · Nature Chemical Biology · 被引 26)
• Targeted Degradation Technologies Utilizing Autophagy (2025 · International Journal of Molecular Sciences · 被引 14)
• Prediction of STAS in lung adenocarcinoma with nodules ≤ 2 cm using machine learning: a multicenter retrospective study (2025 · BMC Cancer · 被引 13)
• Establishment of Hollow Flexible Model with Two Types of Bonds and Calibration of the Contact Parameters for Wheat Straw (2025 · Agriculture · 被引 5)
• Clinical, Electroencephalogram and Imaging Characteristics of Patients With Anti‐LGI1 Antibody Encephalitis: A Multicenter Cohort Study (2025 · CNS Neuroscience & Therapeutics · 被引 4)
• Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS) (2025 · Cancer Research · 被引 3)